Rating History for Mirati Therapeutics (MRTX) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/7/2023 | Andrew Berens | Downgrade | Market Perform (Outperform) |
58.00 (78.00) |
56.27 (58.70) |
4.32% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
